| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2024―Jul―30 |
Providing pharmaceutical care during coronavirus infection (COVID-19) |
L.I. Motygullina, R.G. Tukhbatullina |
| 2 |
[GO] |
2024―Jul―30 |
Clinical and economic evaluation of the use of favipiravir in treatment regimens for COVID-19 |
I.S. Krysanov, K.G. Gurevich, N.V. Matveeva, A.V. Matveev, K.Ya. Zaslavskaya, V.S. Krysanova, et al. (+6) V.Yu. Ermakova, D.V. Kurkin, L.A. Balykova, P.A. Belyi, D.N. Zemskov, E.V. Makarova |
| 3 |
[GO] |
2024―Jul―30 |
Organisation of oncological care in the context of a pandemic: safety measures and changes in treatment |
A.A. Kostin, Yu.V. Samsonov |
| 4 |
[GO] |
2024―Apr―05 |
Megapolis laboratory service: new approaches to managing the morbidity of the population during a pandemic based on methods of mass sequencing of the virus genome |
E. S. Kucheryavykh, Ya. S. Panarina, E. O. Venevtcev, A. G. Komarov, E. I. Aksenova, V. A. Romanova, et al. (+5) A. N. Tsybin, E. A. Slutsky, I. A. Shtinova, O. G. Shpakova, A. S. Beliaeva |
| 5 |
[GO] |
2024―Apr―05 |
Some aspects of the history of epidemics and pandemics |
L. I. Motygullina, R. G. Tukhbatullina |
| 6 |
[GO] |
2023―Jul―14 |
Experience in providing urological care during the COVID-19 pandemic |
A.D. Sarkisyan, T.V. Shapovalenko, S.P. Darenkov, Z.H. Agamov |
| 7 |
[GO] |
2023―Apr―08 |
Comparative analysis of temporary guidelines for the prevention, diagnosis and treatment of new coronavirus infection |
LI Motygullina, RG Tukhbatullina |
| 8 |
[GO] |
2022―Dec―06 |
Laboratory monitoring of successful COVID-19 as part of the in-depth medical care project «Healthy Moscow» |
A. G. Komarov, M. F. Latypova, E. A. Slutsky, A. S. Bezymyanny |
| 9 |
[GO] |
2022―Dec―06 |
Features of the incidence of the working-age population of the city of Moscow by the of diseases of the circulatory system during the COVID-19 pandemic |
V. M. Kuraeva, A. M. Podchernina |
| 10 |
[GO] |
2022―Dec―06 |
Ethical aspects of corporate health promotion programs of medical university employees (by the example of COVID-19 prevention) |
K. V. Zorin, V. A. Toporkov, K. G. Gurevich, D. A. Pustovalov |
| 11 |
[GO] |
2022―Dec―06 |
Quality of life in patients with novel coronavirus infection: association with disease severity and change depending on rehabilitation regimens after inpatient treatment |
A. O. Romanov, A. N. Arkhangelskaya, M. M. Sharipova, K. G. Gurevich |
| 12 |
[GO] |
2022―Dec―06 |
Youth labor market trends in the collision with the «new reality» - sanctions and the pandemic (on the example of the professional field «medicine and pharmacy») |
A. A. Efimova |
| 13 |
[GO] |
2022―Sep―22 |
Changes in body mass index among students from different countries before and during the COVID-19 pandemic |
R. N. Mingazov, S. A. Gureev, A. O. Tliashinov, E. N. Mingazova |
| 14 |
[GO] |
2022―Sep―22 |
Scientific substantiation of the possibility of integrated interagency management in countering global biorisks for public health (by the example of the COVID-19 pandemic) |
D. V. Kaunina, M. D. Vasilyev |
| 15 |
[GO] |
2022―Jun―20 |
COVID-19 burden: emotions of fear in healthcare providers |
E. V. Goncharenko, G. R. Sagitova, O. A. Murzova, E. M. Shaforostova |
| 16 |
[GO] |
2022―Mar―30 |
Socio-medical aspects of dental prosthetics of elderly patients who have had COVID-19 |
A. A. Kopytov, O. A. Volkova, I. V. Ovchinnikov |
| 17 |
[GO] |
2022―Mar―30 |
Economic overview of the Russian pharmaceutical market during the pandemic crisis |
S. A. Bazhenova, E. A. Grammova |
| 18 |
[GO] |
2021―Jul―14 |
COVID-19: не вакциной единой |
Виктор Гандель |
| 19 |
[GO] |
2021―Apr―13 |
Surfactant therapy in combination treatment of COVID-19 related acute respiratory distress syndrome |
Renat R. Gubaidullin, Aleksandr P. Kuzin, Vladimir V. Kulakov |
| 20 |
[GO] |
2021―Apr―13 |
Practice guidelines for the treatment of arterial hypertension in the era of COVID-19: 2020 ISH global hypertension practice review |
Alexey Vodovozov |
| 21 |
[GO] |
2021―Jan―13 |
Experience of using surfactant therapy for pneumonia associated with COVID-19 of obstetric patients |
M.V. Shvechkova, I.I. Kukarskaya, R.N. Marchenko, I.I. Kuratcenko, V.V. Achmatgaraev, E.A. Kukarskaya, A.S. Shvechkova |
| 22 |
[GO] |
2021―Jan―13 |
Clinical trials in the Coronavirus era: management of risks |
Aleksey Vodovozov |
| 23 |
[GO] |
2020―Dec―15 |
Nebulized therapy in the COVID-19 era |
Irina Shirokova, Yuliya Prozherina |
| 24 |
[GO] |
2020―Dec―15 |
Pharmacy market for 9 months 2020: coronavirus and digital |
Nadezhda Kalinina |
| 25 |
[GO] |
2020―Nov―05 |
Public procurement during coronavirus pandemic. Review of tender purchases of J05 Direct-acting antivirals under FZ-44 and FZ-223 |
Nadezhda Kalinina |
| 26 |
[GO] |
2020―Sep―23 |
Pharmacy retail in the age of pandemic |
Nadezhda Kalinina |
| 27 |
[GO] |
2020―Sep―23 |
Inhaled surfactant in patients with COVID-19 who took high-fl ow oxygen therapy: the results of a retrospective analysis |
A.V. Averyanov, T.V. Klypa, O.I. Balionis, M.V. Bychinin, A.V. Chernyak, A.V. Troitskiy |
| 28 |
[GO] |
2020―Jun―11 |
COVID-19 vaccine: seeking salvage |
Yuliya Prozherina |
